🇺🇸 rFVIIa, rFVIIa + TXA in United States

rFVIIa, rFVIIa + TXA (rFVIIa, rFVIIa + TXA) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

rFVIIa, rFVIIa + TXA in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Rare Disease approved in United States

Frequently asked questions

Is rFVIIa, rFVIIa + TXA approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for rFVIIa, rFVIIa + TXA in United States?

Oslo University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.